PIK3C2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.652400E-01
Normal-vs-Stage2
9.914800E-01
Normal-vs-Stage3
4.790200E-02
Normal-vs-Stage4
4.472800E-01
Stage1-vs-Stage2
4.468400E-01
Stage1-vs-Stage3
1.134040E-01
Stage1-vs-Stage4
7.869000E-01
Stage2-vs-Stage3
1.516420E-01
Stage2-vs-Stage4
3.135000E-01
Stage3-vs-Stage4
5.151500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.333000E-01
Normal-vs-AfricanAmerican
6.120200E-01
Normal-vs-Asian
4.965200E-01
Caucasian-vs-AfricanAmerican
3.254800E-01
Caucasian-vs-Asian
3.344000E-01
AfricanAmerican-vs-Asian
1.488420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.273400E-01
Normal-vs-Female
9.933400E-01
Male-vs-Female
7.501800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.447800E-01
Normal-vs-Age(41-60Yrs)
7.132600E-01
Normal-vs-Age(61-80Yrs)
7.360400E-01
Normal-vs-Age(81-100Yrs)
6.843000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.223600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.867600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.837000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.142300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.693840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.049400E-01
Normal-vs-Daily Drinker
1.965840E-01
Normal-vs-Weekly Drinker
5.126000E-01
Normal-vs-Occasional Drinker
8.543600E-01
Normal-vs-Social Drinker
7.727000E-01
Non Drinker-vs-Daily Drinker
6.088200E-02
Non Drinker-vs-Weekly Drinker
4.416400E-01
Non Drinker-vs-Occasional Drinker
3.474000E-01
Non Drinker-vs-Social Drinker
2.979000E-01
Daily Drinker-vs-Weekly Drinker
4.847400E-01
Daily Drinker-vs-Occasional Drinker
3.941600E-02
Daily Drinker-vs-Social Drinker
5.301700E-02
Weekly Drinker-vs-Occasional Drinker
2.029800E-01
Weekly Drinker-vs-Social Drinker
1.743780E-01
Occasional Drinker-vs-Social Drinker
8.080400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.965800E-02
Normal-vs-Grade 2
5.523600E-02
Normal-vs-Grade 3
1.643950E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.266200E-01
Grade 1-vs-Grade 3
3.070800E-01
Grade 1-vs-Grade 4
8.965800E-02
Grade 2-vs-Grade 3
8.018800E-01
Grade 2-vs-Grade 4
5.523600E-02
Grade 3-vs-Grade 4
1.643950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.950200E-01
Normal-vs-NonDiabetic
7.872600E-01
Diabetic-vs-NonDiabetic
8.289600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.682400E-01
Normal-vs-NoPancreatitis
8.211000E-01
Pancreatitis-vs-NoPancreatitis
5.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.859600E-01
Normal-vs-N1
9.932600E-01
N0-vs-N1
5.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.875000E-01
Normal-vs-TP53-NonMutant
8.371600E-01
TP53-Mutant-vs-TP53-NonMutant
5.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
